Partnering with World-Class Institutions
Discovery. Translation. Commercialization.
At ABVC, our focus is to establish strong partnerships with distinguished principal investigators and renowned medical research institutions for the execution of our clinical trials. We prioritize the safety and well-being of our patients by conducting trials under the guidance of world-class doctors.
Australia
Led by Andrew Chang, MD, PhD
Developing Vitargus® in vitrectomy surgery to help retinal surgery patients recover faster and more comfortable.
California, USA
Led by Charles DeBattista MD and Alan F. Schatzberg, MD
Conducting Clinical trials for plant based Major Depressive Disorder drugs.
California, USA
Led by Keith McBurnett, PhD.; Linda Pfiffner, PhD
Conducting Clinical trials for plant based Attention-Deficit Hyperactivity Disorder (ADHD) drugs for Adults.
Taipei Taiwan
Led by Cheng-Ta Li, MD, PhD
Conducting Clinical trials for plant-based Attention-Deficit Hyperactivity Disorder (ADHD) drugs for Adults.
California, USA
Led by Scott Irwin, MD, PhD
Conducting clinical trials for Major Depression in Cancer Patients.
California, USA
Led by Andrew E. Hendifar, MD
Conducting clinical trials for Advanced Inoperable or Metastatic Pancreatic Cancer
Collaborative Partner Institutions
Principal Investigators
Charles Debattista, M.D.
Stanford University Medical Center
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology -Adult)
Principal Investigator
United States Site
ABV-1504 MDD Phase II
Alan F. Schatzberg, M.D.
Stanford University Medical Center
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Principal Investigator
United States Site
ABV-1504 MDD Phase II
Cheng-Ta Li, M.D., Ph.D.
Taipei Veterans General Hospital
Psychiatrist, Department of Psychiatry
Principal Investigator
Taiwan Site
ABV-1504 MDD Phase II
Keith McBurnett, Ph.D.
University of California San Francisco
Professor, Psychiatry, UCSF Weill Institute for Neurosciences, School of Medicine
Principal Investigator
United States Site
ABV-1505 ADHD Phase II
Linda Pfiffner, Ph.D.
University of California San Francisco
Professor, Psychiatry, UCSF Weill Institute for Neurosciences, School of Medicine
Principal Investigator
United States Site
ABV-1505 ADHD Phase II
Scott Irwin, M.D., Ph.D.
Cedars Sinai Medical Center
Professor of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute
Principal Investigator
United States Site
ABV-1601 MDD in Cancer Patients
Andrew Chang, M.D., Ph.D.
Sydney Eye Hospital
Medical Director and Principal Retinal Specialist, Sydney Retina Clinic and Day Surgery
Principal Investigator
Australia Site
ABV-1701 Vitargus FIH for Vitrectomy (Medical Device)
Andrew E. Hendifar, M.D.
Cedars-Sinai Medical Center
Assistant Professor and Medical Director of Pancreatic Cancer
Principal Investigator
United States Site
ABV-1703 Pancreatic cancer Phase II
